Wells Fargo & Company Aclaris Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 4,590 shares of ACRS stock, worth $16,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,590
Previous 4,590 -0.0%
Holding current value
$16,661
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$1.01 - $1.36 $21,480 - $28,924
-21,268 Reduced 82.25%
4,590 $5,000
Q1 2024

May 10, 2024
BUY
$0.92 - $1.44 $5,316 - $8,321
5,779 Added 28.78%
25,858 $32,000
Q4 2023

Feb 09, 2024
BUY
$0.64 - $6.49 $1,146 - $11,630
1,792 Added 9.8%
20,079 $21,000
Q3 2023

Nov 13, 2023
SELL
$6.56 - $10.95 $91,052 - $151,986
-13,880 Reduced 43.15%
18,287 $125,000
Q2 2023

Aug 15, 2023
BUY
$7.89 - $10.64 $118,231 - $159,440
14,985 Added 87.21%
32,167 $333,000
Q1 2023

May 12, 2023
BUY
$7.07 - $17.95 $67,843 - $172,248
9,596 Added 126.5%
17,182 $139,000
Q4 2022

Feb 13, 2023
BUY
$14.33 - $18.37 $21,151 - $27,114
1,476 Added 24.16%
7,586 $119,000
Q3 2022

Nov 14, 2022
SELL
$13.07 - $18.22 $2,836 - $3,953
-217 Reduced 3.43%
6,110 $97,000
Q2 2022

Aug 12, 2022
SELL
$10.16 - $17.08 $340,197 - $571,906
-33,484 Reduced 84.11%
6,327 $89,000
Q1 2022

May 16, 2022
BUY
$9.74 - $17.92 $68,306 - $125,672
7,013 Added 21.38%
39,811 $686,000
Q4 2021

Feb 14, 2022
SELL
$12.27 - $18.49 $1.08 Million - $1.62 Million
-87,751 Reduced 72.79%
32,798 $477,000
Q3 2021

Nov 15, 2021
BUY
$13.38 - $18.8 $1.6 Million - $2.25 Million
119,438 Added 10750.5%
120,549 $2.17 Million
Q2 2021

Aug 16, 2021
SELL
$17.08 - $29.6 $4,765 - $8,258
-279 Reduced 20.07%
1,111 $20,000
Q1 2021

May 13, 2021
SELL
$5.86 - $27.73 $184,859 - $874,770
-31,546 Reduced 95.78%
1,390 $35,000
Q4 2020

Feb 09, 2021
BUY
$2.65 - $7.61 $84,055 - $241,381
31,719 Added 2606.33%
32,936 $213,000
Q3 2020

Nov 05, 2020
SELL
$1.5 - $2.71 $1,528 - $2,761
-1,019 Reduced 45.57%
1,217 $4,000
Q2 2020

Aug 13, 2020
SELL
$1.04 - $1.73 $52,118 - $86,697
-50,114 Reduced 95.73%
2,236 $3,000
Q1 2020

May 14, 2020
BUY
$0.75 - $2.18 $39,262 - $114,123
52,350 New
52,350 $54,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $242M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email